DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundationGP

WHO analgesic approach and multimodal analgesia

Essential points for quick revision.

!
Analgesia alongside definitive emergency care

Severe pain from cord compression, fracture, obstruction, infection, ischaemia or raised intracranial pressure needs immediate relief and disease-specific treatment in parallel.

Action: Give proportionate analgesia by a reliable route, immobilise or stabilise where required and activate the relevant emergency pathway. Do not climb sequential analgesic steps while delaying dexamethasone for neurological MSCC, surgery, antibiotics, drainage, radiotherapy or another time-critical intervention.

Synopsis

Use the WHO cancer-pain framework as a flexible guide, combine mechanism-specific medicines with disease treatment, rehabilitation and psychosocial care, and avoid reflex opioid escalation when a different modality offers greater benefit.

  • The WHO ladder was developed for cancer pain: non-opioid at step one, opioid for mild-to-moderate pain at step two and strong opioid at step three, with adjuvants throughout.
  • Use the ladder flexibly rather than forcing slow progression; severe cancer pain may require a carefully started strong opioid without a prolonged weak-opioid trial.
  • Core principles are an appropriate route, regular treatment for continuous pain, rescue for breakthrough pain, individual titration and attention to detail.

Key red flags

New neurological deficit, pathological fracture features or visceral obstruction requires urgent cause-directed treatment rather than analgesic escalation alone.

Multimodal failure

Escalating toxicity without functional gain suggests the formulation or target is wrong and warrants specialist reassessment.

Investigation priorities

01
First-line mechanism and severity formulationFirst stepFirst line

Identify nociceptive, neuropathic, inflammatory, mechanical and psychosocial contributors and the need for urgent disease treatment.

Management branches

Analgesic selectionChoose intensity and modality by mechanism

Pain requires a new or revised treatment plan after emergency causes have been addressed.

  1. Formulate pain mechanisms and severity, define a functional goal and identify disease-directed, physical and psychosocial treatments that can alter the cause.
  2. Select non-opioid, opioid and adjuvant components with organ function and interactions considered, moving directly to carefully titrated strong opioid when severe cancer pain warrants it.

Key medicines

Paracetamol for selected nociceptive painFor an adult at least 50 kg without relevant risk, 500 mg to 1 g orally every 4 to 6 hours when required, maximum 4 g in 24 hours; use a lower maximum when low weight, frailty, malnutrition, alcohol excess or liver disease requires it.
Ibuprofen as a short anti-inflammatory trialWhen appropriate, use 200 to 400 mg orally up to three times daily with or after food for the shortest necessary course, following the BNF and local gastroprotection policy.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom